MACK JOHNSON, O.D.
Optometrist in GUYMON, Oklahoma. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
MACK JOHNSON, O.D. reported a CMS MIPS final score of 0/100 — below the 83.1 national average — and filed 389 Medicare Part D claims in 2023.
- 0/100
- MIPS score · -83 vs avg
- 389
- Part D claims, 2023
- 60%
- generic prescribing
- $18.21
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
MACK JOHNSON, O.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
0 0th percentile higher than 0% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
What does the federal data show about MACK JOHNSON, O.D.?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Oklahoma
How Optometrist compares to other specialties among Oklahoma providers
Optometrist share within Oklahoma
Optometrist is one of the more visible NUCC categories in Oklahoma
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
MACK JOHNSON, O.D.'s 2023 MIPS final score plotted against the Optometrist national average
- MIPS Final Score
- 0/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Optometrist) — 0/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Optometrist US NPIs
0/100 MIPS final score — 83.1 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Optometrist. Quality dim: 0.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
MACK JOHNSON, O.D. appears in the CMS NPPES registry as a Optometrist provider holding O.D. credentials at 301 NORTHRIDGE CIR, GUYMON, OK, 73942, with a listed phone of (580) 338-8437. NPI 1831107986 was issued on 08/04/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what JOHNSON most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 389 prescription claims written by this provider, covering 88 Medicare beneficiaries and totaling roughly $34K in drug spend, split 40% brand-name and 60% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 0/100 for the 2023 performance year (Quality 0), compared with the national average of 83.1.
Optometrist is a high-volume specialty nationwide, with 60,463 enrolled providers across 56 states and an average of 257 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1831107986 |
|---|---|
| Specialty | Optometrist |
| Credentials | O.D. |
| Gender | Male |
| NPI Issued | 08/04/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm MACK JOHNSON, O.D.'s current license status, disciplinary history, and board certifications with the Oklahoma State Board of Medical Licensure in Oklahoma before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MACK JOHNSON, O.D.. Source: openpaymentsdata.cms.gov.
Total received
$18
Largest payer
CooperVision Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
40% brand-name claims vs 60% generic, on 389 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 471
- Total Day Supply
- 11,853
- Brand vs Generic
- 40% brand / 60% generic
- Brand Drug Cost
- $29K
- Generic Drug Cost
- $6K
- Antibiotic Claims
- 17
Patient Demographics
- Average Patient Age
- 75.3 years
- Avg HCC Risk Score
- 1.04
- Gender Split
- 68% female / 32% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What MACK JOHNSON, O.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Latanoprost
Latanoprost
83 claims
- Prednisolone Acetate
Prednisolone Acetate
55 claims
- Timolol Maleate
Timolol Maleate
51 claims
- Brimonidine Tartrate
Brimonidine Tartrate
42 claims
- Combigan 25
Combigan
25 claims
- Neomycin-Polymyxin… 21
Neomycin-Polymyxin-Dexameth
21 claims
- Vyzulta 20
Vyzulta
20 claims
- Brimonidine Tartra… 16
Brimonidine Tartrate-Timolol
16 claims
| Drug | Claims |
|---|---|
| Latanoprost | 83 |
| Prednisolone Acetate | 55 |
| Timolol Maleate | 51 |
| Brimonidine Tartrate | 42 |
| Combigan Brimonidine Tartrate/Timolol | 25 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 21 |
| Vyzulta Latanoprostene Bunod | 20 |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 16 |
| Doxycycline Hyclate | 16 |
| Restasis Cyclosporine | 14 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Optometrist Overview
How MACK JOHNSON, O.D. fits within the Optometrist landscape nationally.
MACK JOHNSON, O.D.'s 389 claims are above the specialty average of 257.
Nearby Optometrist Providers in Oklahoma
Other clinicians with the same primary specialty enrolled in Oklahoma, drawn from the same CMS NPPES roster as JOHNSON.
Compare Optometrist nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Oklahoma
Frequently Asked Questions
What is MACK JOHNSON, O.D.'s specialty? ▼
How much does MACK JOHNSON, O.D. prescribe under Medicare Part D? ▼
What is MACK JOHNSON, O.D.'s Medicare quality score? ▼
Where is MACK JOHNSON, O.D. located? ▼
What is MACK JOHNSON, O.D.'s NPI number? ▼
Does MACK JOHNSON, O.D. prescribe more brand-name or generic drugs? ▼
How many Optometrist providers are there in the US? ▼
What drugs does MACK JOHNSON, O.D. prescribe most often? ▼
Does MACK JOHNSON, O.D. accept Medicare? ▼
How can I verify MACK JOHNSON, O.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology